Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,358 | -2,583 | -1,720 | -751 | -3,765 |
| Depreciation Amortization | 806 | 603 | 402 | 201 | 8 |
| Income taxes - deferred | -603 | -442 | -301 | -130 | -903 |
| Accounts payable and accrued liabilities | -217 | -227 | -149 | -9 | 241 |
| Other Working Capital | -180 | -163 | 43 | -4 | 189 |
| Other Operating Activity | 801 | 676 | 310 | 86 | 521 |
| Operating Cash Flow | $-2,750 | $-2,137 | $-1,415 | $-607 | $-3,708 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -22 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -22 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 805 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 2,875 |
| Other Financing Activity | 896 | 900 | 396 | 115 | -251 |
| Financing Cash Flow | $1,701 | $900 | $396 | $115 | $2,624 |
| Beginning Cash Position | 1,741 | 1,741 | 1,741 | 1,741 | 2,847 |
| End Cash Position | 692 | 504 | 722 | 1,249 | 1,741 |
| Net Cash Flow | $-1,049 | $-1,237 | $-1,019 | $-492 | $-1,107 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,750 | -2,137 | -1,415 | -607 | -3,708 |
| Free Cash Flow | -2,750 | -2,137 | -1,415 | -607 | -3,708 |